Latest Kaiser Health News Stories
Obria, a Christian medical chain, was awarded federal family planning funds for its California clinics for the first time this year. Clinics receiving Title X funds are expected to treat and prevent sexually transmitted diseases. Obria’s prohibition against condoms means its prevention efforts rest on abstinence, even as STD rates surge.
Unlike in the U.S., health insurance in Germany doesn’t cover birth control. German health advocates say that causes health problems — but change is unlikely.
President Donald Trump, dogged by an impeachment inquiry, tries to change the subject by unveiling an executive order aimed at expanding the role of private Medicare health plans. The Trump administration also launched an effort this week to expand “wellness” programs aimed at getting people with insurance to practice better health habits – even though research has shown the efforts don’t generally improve health or save money. This week, Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
More insurers are experimenting with paying health care providers one lump sum to cover the cost of maternity care. Physicians and insurers hope the model — known as bundled payments — will help improve health outcomes.
The legal fight over the Trump administration’s new rule barring health clinics that receive federal family planning grants from referring women for abortion services played out before a divided federal appeals court Monday. Here are key takeaways.
The Austin City Council is setting aside $150,000 in city funds to help local women seeking an abortion pay for related costs, such as transportation or child care.
State attorneys general took legal action to stop the sale of rape kits that would be useless as evidence in court.
Two companies are selling at-home rape kits as the latest direct-to-consumer product, but hardly anyone thinks this is a good idea.
President Donald Trump keeps promising a new health plan, but so far it’s nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews KHN’s Rachel Bluth about the latest “Bill of the Month” feature. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
A proposed state law would require on-campus health centers to provide students with the medicines that allow them to end an unwanted pregnancy. Former Gov. Jerry Brown vetoed a similar bill last year, but Gov. Gavin Newsom has said he would sign it.
In response to recent high-profile sex abuse cases, some California lawmakers want doctors to give patients more information about pelvic exams, and then get a signature proving they did. Doctors in the Golden State and beyond are pushing back.
The Trump administration’s policy shift on Title X family planning funds is likely to make birth control harder to get and more expensive for low-income women. It will also shift funds from organizations like Planned Parenthood to the Obria Group, which does not give women hormonal contraceptives or condoms in its clinics.
Liberalized sex education policies are being considered in more states, even traditionally conservative ones, as more female lawmakers take office and legislators react to the #MeToo movement.
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.